Essential Psychopharmacology Volume 5

By Hatherleigh Medical Education


Essential Psychopharmacology Volume 5 is organized by Hatherleigh Medical Education.

Target Audience:
The primary target audience for this program includes, but is not limited to addiction treatment professionals, primary care physicians, psychiatrists, psychiatric nurses, clinical psychologists, pharmacists, and social workers. Clinicians who have caseloads composed significantly of individuals with psychiatric disorders, comorbid medical illnesses, and substance use and addictive disorders will find this course particularly useful.

Credits: CE/CME Hours: 10

Course Curriculum:
Genetic Basis of the Efficacy and Tolerability of Antipsychotic Drugs: A Review*
Naloxone and Naltrexone: The Story of Opioid Antagonists*

• Medication-Assisted Therapy and Psychosocial Treatment for Opioid Use Disorders:
? Recipe for Successful Integration to Improve Outcomes and
? Retention and to Prevent Death—Part 1*

• Medication-Assisted Therapy and Psychosocial Treatment for Opioid Use Disorders:
? Recipe for Successful Integration to Improve Outcomes and
? Retention and to Prevent Death—Part 2*

Initiation of Buprenorphine in the Emergency Room Setting*

Overall Objective: 
The objective of this continuing medical education (CME) program is to present participants with an expanded clinical skill set and raised awareness of clinically relevant issues in their profession. Participants will review the history behind psychopharmacology and the changes in its criteria over time, and how psychopharmacology is used among various population groups. Upon completion of the program, participants will be better equipped to face the challenges of daily practice while providing evidence-based care to patients and clients. The expected outcomes include an increase in knowledge, competence, professionalism, and performance.


Registration Name Category Last Date Price
Digital Only Course Registration Fee USD 55.00
Digital Plus Print Course Registration Fee USD 65.00


  • Opioid use disorder

Credit Info

American Medical Association
The Hatherleigh Company, Ltd. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Hatherleigh Company, Ltd. designates this CME activity for a maximum number of 10 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Psychological Association
The Hatherleigh Company, Ltd. is approved by the American Psychological Association to sponsor continuing education for psychologists. Hatherleigh maintains responsibility for the program and its' content.

The American Nurses Credential Center’s Commission on Accreditation (ANCC) accepts CE programs by an American Psychological Association approved provider.

  • CME : 10


  • Psychology
  • Clinical Pharmacology
  • Pharmacy and Medicine

Target Audience

  • Pharmacist
  • Social Worker
  • Psychiatrists and Psychologists
  • Physicians
  • Clinicians
  • Healthcare Professionals
  • Nurses

Contact Us


Toll free Number

1(800) 828-2059


Chat Assistant

Live Chat

Participant Reviews

Recommended Conferences

Precision Medicine: Evidence Based Development and Practice (10 Modules Bundle)
Webcast Mar 25, 2022 - Mar 31, 2023

Healthcare Management +12 More

AMA PRA Category 1 Credit™ 10

USD 699

The Science of Psychedelics: Training for Medical Professionals
Webcast Feb 14, 2021 - Feb 14, 2026

Psychiatry +1 More

CME 8 +

CAD 575

Bundle #1: Directions in Psychiatry 36/37/38
Text-Based CME


AMA PRA Category 1 Credit™ 120

USD 450

Medical Books